The survey is encouraging. It indicates that perhaps physicians have finally begun to understand the serious health risks that transvaginal mesh products pose to patients.
Athens, GA (PRWEB) November 08, 2012
Defective transvaginal mesh lawyer Henry G. Garrard III of the Athens, Georgia law firm of Blasingame, Burch, Garrard & Ashley, P.C., said today that a report that fewer surgeons are using mesh for the treatment of pelvic organ prolapse (POP) after a 2011 U.S. Food and Drug Administration safety communication about the products is an encouraging sign.
Renal & Urology News reported in October that a survey of surgeons indicated that specialists had decreased their use of mesh products for recurrent vaginal POP repair in the wake of the FDA’s transvaginal mesh safety communication in July 2011. The survey was presented at the Annual Scientific Meeting of the American Urogynecologic Society.
“The survey is encouraging. It indicates that perhaps physicians have finally begun to understand the serious health risks that transvaginal mesh products pose to patients,” said Garrard, one of the country’s leading defective transvaginal mesh attorneys.
“The FDA told doctors in its safety communication what we have been saying all along, and that is that there is inadequate evidence that the use of transvaginally placed mesh in POP repair improves clinical outcomes compared with non-mesh POP repair, and it exposes patients to certain risks that simply are not present with traditional POP repair.”
Blasingame, Burch, Garrard & Ashley, P.C., has investigated the cases of women across the country that were implanted with transvaginal mesh products to treat pelvic organ prolapse (POP) and/or stress urinary incontinence (SUI).
Garrard currently serves as co-lead counsel for the plaintiffs in four multidistrict litigation cases:
- In re C.R. Bard, Inc. Pelvic Repair Systems Products Liability Litigation (MDL No. 2187)
- In re American Medical Systems, Inc. Pelvic Repair Systems Products Liability Litigation (MDL No. 2325)
- In re Boston Scientific Corp. Pelvic Repair Systems Products Liability Litigation (MDL No. 2326)
- In re Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation (MDL No. 2327)
Garrard’s law firm spearheaded the effort to have the lawsuits centralized in the U.S. District Court for the Southern District of West Virginia and is now preparing for the first bellwether trial in the Bard MDL, which is set for Spring 2013.
“Cases against mesh product manufacturers are ongoing, and an experienced transvaginal mesh attorney can assist patients who have suffered injury from these products and deserve compensation for those injuries,” he said.“The failure of transvaginal mesh products represents a serious breach of the public trust that our firm will continue to pursue.”
About Blasingame, Burch, Garrard & Ashley, P.C.
Blasingame, Burch, Garrard & Ashley, P.C., is an Athens, Georgia-based law firm that has been widely recognized for its ethics, skill and professionalism by Martindale-Hubbell®, The Best Lawyers in America, American College of Trial Lawyers, Super Lawyers and Law & Politics Media/Atlanta Magazine. Since 2006, the firm’s defective medical device and product liability lawyers have pursued claims involving defective transvaginal mesh products, including handling attorney referrals from co-counsel across the country. The firm’s office is located at 440 College Avenue, Athens, GA 30603 (local phone (706) 354-4000). For more information, call the firm at (866) 354-3544 or use its online contact form.